Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders??? Deficit

v3.22.2.2
Condensed Consolidated Statements of Convertible Preferred Stock, Contingently Redeemable Convertible Common Stock and Stockholders’ Deficit - USD ($)
$ in Thousands
Total
Previously Reported
Convertible Preferred Stock
Convertible Preferred Stock
Previously Reported
Convertible Preferred Stock
Revision of Prior Period, Adjustment
Contingently redeemable convertible common stock
Contingently redeemable convertible common stock
Previously Reported
Contingently redeemable convertible common stock
Revision of Prior Period, Adjustment
Common Stock
Common Stock
Previously Reported
Common Stock
Revision of Prior Period, Adjustment
Additional Paid-In Capital
Additional Paid-In Capital
Previously Reported
Accumulated
Deficit
Accumulated
Deficit
Previously Reported
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2020 [1]     114,795,000 97,611,000 17,184,000                    
Temporary equity, balances at beginning of period at Dec. 31, 2020 [1]     $ 487,918 $ 487,918                      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]     114,795,000                        
Temporary equity, balances at ending of period at Jun. 30, 2021 [1],[2]     $ 487,918                        
Balances at beginning of period (in shares) at Dec. 31, 2020 [1]                 8,468,000 7,200,000 1,268,000        
Balances at beginning of period at Dec. 31, 2020 $ (339,641) $ (339,641)             $ 1 [1] $ 1 [1]   $ 14,605 $ 14,605 $ (354,247) $ (354,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Conversion of preferred stock warrant liability to common stock warrants 1,622                     1,622      
Issuance of common stock for services (in shares) [1]                 4,000            
Issuance of common stock for services 49                     49      
Issuance of common stock upon exercise of stock options (in shares) [1]                 522,000            
Issuance of common stock upon exercise of stock options 517                     517      
Vesting of early exercise of options 1,245                     1,245      
Repurchase of early exercised options (in shares) [1]                 (155,000)            
Issuance of common stock warrants 1,622                     1,622      
Stock-based compensation 7,344                     7,344      
Net loss (66,411)                         (66,411)  
Balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]                 8,839,000            
Balances at ending of period at Jun. 30, 2021 (395,275)               $ 1 [1],[2]     25,382   (420,658)  
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2021 [2]     114,795,000 97,611,000 17,184,000                    
Temporary equity, balances at beginning of period at Mar. 31, 2021 [2]     $ 487,918 $ 487,918                      
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]     114,795,000                        
Temporary equity, balances at ending of period at Jun. 30, 2021 [1],[2]     $ 487,918                        
Balances at beginning of period (in shares) at Mar. 31, 2021 [2]                 8,619,000 7,329,000 1,290,000        
Balances at beginning of period at Mar. 31, 2021 (372,739) (372,739)             $ 1 [2] $ 1 [2]   19,402 19,402 (392,142) (392,142)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Conversion of preferred stock warrant liability to common stock warrants 1,622                     1,622      
Issuance of common stock for services (in shares) [2]                 4,000            
Issuance of common stock for services 49                     49      
Issuance of common stock upon exercise of stock options (in shares) [2]                 216,000            
Issuance of common stock upon exercise of stock options 227                     227      
Vesting of early exercise of options 221                     221      
Issuance of common stock warrants 1,622                     1,622      
Stock-based compensation 3,861                     3,861      
Net loss (28,516)                         (28,516)  
Balances at ending of period (in shares) at Jun. 30, 2021 [1],[2]                 8,839,000            
Balances at ending of period at Jun. 30, 2021 $ (395,275)               $ 1 [1],[2]     25,382   (420,658)  
Temporary equity, balances at beginning of period (in shares) at Dec. 31, 2021 114,795,034   114,795,000 [3] 97,611,000 [3] 17,184,000 [3] 0 [3] 0 [3]                
Temporary equity, balances at beginning of period at Dec. 31, 2021 $ 487,918   $ 487,918 [3] $ 487,918 [3]   $ 0 [3] $ 0 [3]                
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [3]     168,000                        
Issuance of preferred stock and common stock upon net exercise of warrants [3]     $ 989                        
Conversion of preferred stock warrant liability to common stock warrants $ 516,380               $ 12 [3]     516,368      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]     (114,963,000)     (2,750,000)                  
Convertible preferred stock and contingently redeemable common stock conversion [3]     $ (488,907)     $ (27,473)                  
Issuance of convertible common stock (in shares) [3]           2,750,000                  
Issuance of convertible common stock [3]           $ 27,473                  
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 0   0 [3],[4]     0 [3],[4]                  
Temporary equity, balances at ending of period at Jun. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                  
Balances at beginning of period (in shares) at Dec. 31, 2021 [3]                 9,368,000 7,966,000 1,402,000        
Balances at beginning of period at Dec. 31, 2021 (456,279) (456,279)             $ 1 [3] $ 1 [3]   33,863 33,863 (490,143) (490,143)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [3]                 156,000            
Conversion of preferred stock warrant liability to common stock warrants 2,182                     2,182      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [3]                 118,205,000            
Convertible preferred stock and contingently redeemable common stock conversion 516,380               $ 12 [3]     516,368      
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares) [3]                 20,921,000            
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981               $ 2 [3]     79,979      
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)                     (93,196)      
Issuance of Earn-Out Shares (in shares) [3]                 14,000,000            
Issuance of Earn-Out Shares 1               $ 1 [3]            
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [3]                 32,000            
Issuance of Class A common stock issued to employees, net of withholding taxes $ (96)                     (96)      
Issuance of common stock upon exercise of stock options (in shares) 205,337               205,000 [3]            
Issuance of common stock upon exercise of stock options $ 333                     333      
Vesting of early exercise of options 125                     125      
Repurchase of early exercised options (in shares) [3]                 (17,000)            
Issuance of common stock warrants 2,182                     2,182      
Stock-based compensation 24,785                     24,785      
Net loss (82,694)                         (82,694)  
Balances at ending of period (in shares) at Jun. 30, 2022 [3],[4]                 162,870,000            
Balances at ending of period at Jun. 30, 2022 (8,478)               $ 16 [3],[4]     564,343   (572,837)  
Temporary equity, balances at beginning of period (in shares) at Mar. 31, 2022 [4]     114,795,000 97,611,000 17,184,000 2,750,000 2,350,000 400,000              
Temporary equity, balances at beginning of period at Mar. 31, 2022 [4]     $ 487,918 $ 487,918   $ 27,473 $ 27,473                
Increase (Decrease) in Temporary Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [4]     168,000                        
Issuance of preferred stock and common stock upon net exercise of warrants [4]     $ 989                        
Conversion of preferred stock warrant liability to common stock warrants $ 516,380               $ 12 [4]     516,368      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [4]     (114,963,000)     (2,750,000)                  
Convertible preferred stock and contingently redeemable common stock conversion [4]     $ (488,907)     $ (27,473)                  
Temporary equity, balances at ending of period (in shares) at Jun. 30, 2022 0   0 [3],[4]     0 [3],[4]                  
Temporary equity, balances at ending of period at Jun. 30, 2022 $ 0   $ 0 [3],[4]     $ 0 [3],[4]                  
Balances at beginning of period (in shares) at Mar. 31, 2022 [4]                 9,455,000 8,040,000 1,415,000        
Balances at beginning of period at Mar. 31, 2022 (498,866) $ (498,866)             $ 1 [4] $ 1 [4]   38,660 $ 38,660 (537,527) $ (537,527)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Issuance of preferred stock and common stock upon net exercise of warrants (in shares) [4]                 156,000            
Conversion of preferred stock warrant liability to common stock warrants 2,182                     2,182      
Convertible preferred stock and contingently redeemable common stock conversion (in shares) [4]                 118,205,000            
Convertible preferred stock and contingently redeemable common stock conversion 516,380               $ 12 [4]     516,368      
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $7.1 million transaction costs (in shares) [4]                 20,921,000            
Issuance of common stock in connection with Business Combination, including Backstop Tranche 2 Shares and PIPE offering, net of $17.1 million in transaction costs 79,981               $ 2 [4]     79,979      
Additional Shares liability, Earn-Out liability and Public and Private Placement Warrants recognized upon Business Combination (93,196)                     (93,196)      
Issuance of Earn-Out Shares (in shares) [4]                 14,000,000            
Issuance of Earn-Out Shares 1               $ 1 [4]            
Issuance of Class A common stock issued to employees, net of withholding taxes (in shares) [4]                 32,000            
Issuance of Class A common stock issued to employees, net of withholding taxes (96)                     (96)      
Issuance of common stock upon exercise of stock options (in shares) [4]                 118,000            
Issuance of common stock upon exercise of stock options 162                     162      
Repurchase of early exercised options (in shares) [4]                 (17,000)            
Issuance of common stock warrants 2,182                     2,182      
Stock-based compensation 20,284                     20,284      
Net loss (35,310)                         (35,310)  
Balances at ending of period (in shares) at Jun. 30, 2022 [3],[4]                 162,870,000            
Balances at ending of period at Jun. 30, 2022 $ (8,478)               $ 16 [3],[4]     $ 564,343   $ (572,837)  
[1] (1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
[2]
(1) The shares of the Company’s common and convertible preferred stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[3]
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.
[4]
(1) The shares of the Company’s common, convertible preferred stock and contingently redeemable convertible common stock prior to the Closing of the Business Combination (as defined in Note 1) have been retroactively restated to reflect the exchange ratio of approximately 1.1760 established in the Merger Agreement as described in Note 3.
The accompanying notes are an integral part of these condensed consolidated financial statements.